These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3133121)

  • 1. Transdermal drug delivery: a review of pharmaceutics, pharmacokinetics, and pharmacodynamics.
    Moore L; Chien YW
    Crit Rev Ther Drug Carrier Syst; 1988; 4(4):285-349. PubMed ID: 3133121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing of controlled-release transdermal dosage forms. Product development and clinical trials.
    Shaw JE; Prevo ME; Amkraut AA
    Arch Dermatol; 1987 Nov; 123(11):1548-56. PubMed ID: 2960274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic systems and drug delivery. 3. Transdermal therapeutic systems].
    Davila D; Karleusa-Simanović A; Davila T
    Lijec Vjesn; 1990; 112(7-8):235-43. PubMed ID: 2292898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models.
    Godin B; Touitou E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1152-61. PubMed ID: 17889400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hercon technology for transdermal delivery of drugs.
    Shah KR; Ng S; Zeoli L; Haight V; Matz S; Kydonieus AF
    J Biomater Appl; 1986 Oct; 1(2):239-73. PubMed ID: 3146634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal delivery systems.
    Merkle HP
    Methods Find Exp Clin Pharmacol; 1989 Mar; 11(3):135-53. PubMed ID: 2657273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Your CE topic (No. 111). Clinical application of transdermal drug delivery systems (Part II).
    Lackner TE
    J Pract Nurs; 1990 Mar; 40(1):42-50. PubMed ID: 2109799
    [No Abstract]   [Full Text] [Related]  

  • 8. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
    Henzl MR; Loomba PK
    J Reprod Med; 2003 Jul; 48(7):525-40. PubMed ID: 12953327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on transdermal delivery system of isosorbide dinitrate].
    Ji AM; Jiang XT; Wang XF; Zou HQ
    Yao Xue Xue Bao; 1992; 27(11):858-63. PubMed ID: 1300032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous penetration enhancers: an overview.
    Thong HY; Zhai H; Maibach HI
    Skin Pharmacol Physiol; 2007; 20(6):272-82. PubMed ID: 17717423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization.
    Zhao JH; Fu JH; Wang SM; Su CH; Shan Y; Kong SJ; Wang Y; Lu WL; Zhang H; Zhang S; Li L; Zhang EH; Wang L; Pei QL; Wang JC; Zhang X; Zhang Q
    Int J Pharm; 2007 Jun; 337(1-2):88-101. PubMed ID: 17267147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal therapeutic systems and rate controlled drug delivery.
    Yum SI
    Med Prog Technol; 1989; 15(1-2):47-52. PubMed ID: 2530425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal drug delivery and cutaneous metabolism.
    Guy RH; Hadgraft J; Bucks DA
    Xenobiotica; 1987 Mar; 17(3):325-43. PubMed ID: 3107225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal drug delivery: basic principles for the veterinarian.
    Mills PC; Cross SE
    Vet J; 2006 Sep; 172(2):218-33. PubMed ID: 16324855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal delivery of drugs.
    Brown L; Langer R
    Annu Rev Med; 1988; 39():221-9. PubMed ID: 3130771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation development, in vitro and in vivo evaluation of membrane controlled transdermal systems of glibenclamide.
    Mutalik S; Udupa N
    J Pharm Pharm Sci; 2005 Jan; 8(1):26-38. PubMed ID: 15946595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal drug delivery: useful paradigms.
    Potts RO; Cleary GW
    J Drug Target; 1995; 3(4):247-51. PubMed ID: 8820998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin permeation: the years of enlightenment.
    Hadgraft J; Lane ME
    Int J Pharm; 2005 Nov; 305(1-2):2-12. PubMed ID: 16246513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.